Objective: In heart failure, cardiac energy metabolism is compromised. The failing myocardium is characterized by reduced contents of both phosphorylated (phosphocreatine) and non-phosphorylated (free) creatine content as well as decreased energy reserve via creatine kinase (creatine kinase reaction velocity). These changes may contribute to cardiac dysfunction. The purpose of the present study was to determine whether chronic feeding with high-dose dietary creatine prevents the derangement of energy metabolism and the development of left ventricular remodeling in a rat model of heart failure, i.e. post-myocardial infarction (MI). Methods and results: Rats were subjected to sham operation or left coronary artery ligation. Surviving rats were fed with 0% (untreated) or 3% creatine (related to weight of diet) for 8 weeks. Creatine feeding increased serum creatine levels significantly |2-fold. Thereafter, hearts were isolated, perfused and left ventricular pressure-volume curves obtained. Steady state and dynamic (CK reaction velocity) high-energy phosphate metabolism 31 was determined with P NMR spectroscopy. In both MI groups (treated n58, untreated n57), pressure-volume curves were shifted right-and downward compared to both sham groups (treated n55, untreated n57), i.e. creatine had no effect on left ventricular remodeling. Likewise, similar reductions of phosphocreatine, free creatine and creatine kinase reaction velocity (untreated sham 12.060.7 mmol / l3s; untreated MI 7.860.7*; treated sham 13.661.0; treated MI 7.261.1*; * p,0.025 sham vs. MI) were found in both MI groups. Conclusions: Chronic creatine feeding of post-MI rats is ineffective in preventing the functional and energetic derangements occurring post-MI. Inspite of increased serum creatine levels, neither the normal nor the failing heart accumulates additional creatine.
Introduction
conceivable that changes in creatine metabolism and creatine kinase (CK) kinetics contribute to contractile Both experimental [1] [2] [3] and clinical studies [4] [5] [6] [7] have dysfunction (see Ref.
[9] for a review). Compounds of shown that the hypertrophied and failing myocardium is proven therapeutic benefit in heart failure such as betacharacterized by a depletion of creatine compounds, i.e. receptor-blockers [10] or angiotensin-converting enzyme both phosphorylated (phosphocreatine) and unphosinhibitors [2, 11] were shown to increase (phospho-) phorylated ('free') creatine are decreased. The reduction of creatine content and CK reaction velocity in experimental phosphocreatine is largely responsible for the substantial heart failure models in parallel with their beneficial decrease of energy reserve via creatine kinase (creatine functional effects, but these compounds do not primarily kinase reaction velocity, or 'flux') in the failing heart act on energy metabolism. Thus, it would be interesting to [1, 2, 8] . Although direct proof has been difficult, it is well study interventions that primarily and specifically increase creatine content and, therefore, improve CK kinetics in heart failure, and to test for their possible beneficial functional effects. Cardiomyocytes do not synthesize Burnie, MD) with a small-bore polyethylene tubing for creatine but accumulate the compound against a large continuous measurement of left ventricular pressure and concentration gradient through the action of the specific heart rate on a MacLab system (version 3.5, AD instru-1 Na -creatine cotransporter protein [12] . Studies in athletes ments, Castle Hill, Australia). Left ventricular pressurehave shown that creatine content of skeletal muscle can be volume curves were obtained by increasing balloon volincreased 15-20% by chronically supplying high dosages ume in a stepwise manner (delta 0.05 ml) until maximum of creatine with the diet, and that skeletal muscle work LVDP was reached or until LVEDP exceeded 50 mmHg. output increases in parallel [13, 14] , although in rat, this has Thereafter, LVEDP was set to 10 mmHg for the duration not been observed [15] .
of the NMR measurements. At the end of the protocol, Based on these observations, purpose of the present hearts were taken off the cannula, and the right ventricle work was to study the effects of chronically supplying high was cut off and rapidly frozen. The entire left ventricle was dietary dosages of creatine on myocardial creatine and fixed in formalin as previously described for histologic phosphocreatine content and on cardiac structure and determination of infarct size. function in a clinically highly relevant model of heart failure, i.e. the rat heart post-myocardial infarction (MI). If 2.3. Determination of infarct size successful, oral creatine might have been a novel approach to the treatment of chronic heart failure. However, our Infarct size was determined by a previously described results indicate that, inspite of substantially increased technique [1] . The left ventricle was embedded in paraffin, extracellular creatine concentrations, neither the normal and 20-mm sections were cut serially from apex to base of nor the failing heart increases its creatine content.
the heart. Sections were stained with Picrosirius Red and were mounted on glass plates, scanned (Nikon EF scanner, Nikon, Japan) and planimetry was performed with the NIH
Methods
Image software (version 1.59, National Institutes of Health). Lengths of scar and non-infarcted muscle for both 2.1. Animals and experimental myocardial infarction endocardial and epicardial surfaces were determined for each section. The ratio of the lengths of scar and surface Infarcts or sham operations were carried out in 12-weeks circumferences defined the infarct size for endo-and old Wistar rats as previously described [1, 16] . The left epicardial surfaces, respectively. Final infarct size was coronary artery was ligated after left thoracotomy under determined as the average of endo-and epicardial surfaces ether anesthesia. Mortality rate of infarcted rats for the first and is given in percent. All hearts with an infarct size of 24 h after the operation was 40-50%. The investigation less than 25% were excluded from the analysis. conforms with the Guide for the Care and Use of The perfused hearts were placed into a 20-mm NMR sample tube and inserted into a probe seated in the bore of 2.2. Isolated heart preparation a superconducting super-wide-bore (150 mm) 7.05 Tesla magnet (Bruker, Rheinstetten, FRG) as previously deRats were re-anesthetized by injecting 50 mg penscribed [1, 11, 18] . Hearts were bathed in their own perfutobarbital sodium intraperitoneally. After thoracotomy, the sate. An Aspect 3000 computer (Bruker, Rheinstetten, heart was rapidly excised and immersed in ice-cold buffer.
FRG) was used in the pulsed Fourier transform mode to 31 The aorta was dissected free, and mounted onto a cannula generate P NMR spectra at 121.50 MHz. A 14-channel attached to a perfusion apparatus, as previously described Shim Unit served to homogenize the magnetic field. Single [17] . Retrograde perfusion of the heart was started in the ('one pulse') spectra were accumulated over 5-min Langendorff mode at a constant temperature of 378C and a periods, averaging data from 152 free induction decays constant coronary perfusion pressure of 100 mmHg. For obtained using a pulse time of 37.6 ms, a pulse angle of perfusion, phosphate-free Krebs-Henseleit buffer was used 458 and an interpulse delay of 1.93 s. The resonance areas as described [17] . Coronary flow was measured by an corresponding to ATP, phosphocreatine, inorganic phosultrasonic flow probe (Transonic Systems Inc., Ithaca, phate, monophosphate esters and NAD, which are propor-NY). As previously shown, the perfusion system allowed tional to the number of phosphorus atoms of the respective maintenance of hearts in a steady state for at least 90 min compound, were measured using the NMR1 software with changes of less than 5% for all mechanical and package (Tripos, St. Louis, MO) and were corrected for metabolic parameters [17] . For measurement of cardiac partial saturation. In each heart, the area of the [g-P]ATP performance, a water-filled latex balloon was inserted into resonance of the first spectrum obtained under control the left ventricle. The balloon was connected to a Statham conditions was arbitrarily set to 100% and used as the The cytosolic phosphorylation potential (PP; M ) was tissue of MI hearts as 10.660.8 mmol / l [1] . Since the calculated as described [24] as: protocol (histologic determination of left ventricular infarct PP 5 ATP: (ADP 3 inorganic phosphate) size, cutoff of right ventricle for creatine analysis within |20 s) did not allow absolute ATP quantification by where ADP (mmol / l) is HPLC, ATP concentrations for sham and MI hearts were assumed to be the same as for the previous study [1] . In 1 (ATP 3 creatine): (phosphocreatine 3 H 3 K ), eq addition, it was assumed that chronic creatine feeding does not increase ATP above normal values and does not 1 H is the intracellular hydrogen ion concentration, and K eq decrease ATP in sham or MI hearts, both assumptions very is the equilibrium constant of the creatine kinase reaction likely to be correct: ATP cannot increase above normal 29 21 (1.66310 M ) [1] . levels, since mitochondrial ATP production is subject to close feedback inhibition by ATP; chronic creatine feeding does not decrease myocardial ATP content, as was previ-2.8. Experimental groups and protocols ously shown [15] . Intracellular pH (pH ) was measured by i comparing the chemical shift between inorganic phosphate Four groups of rats were studied: Sham operated unand phosphocreatine with values obtained from a standard treated (Sh; n57), infarcted untreated (MI; n57), sham curve [19] .
operated treated (Sh1Cr; n55) and infarcted treated (MI1Cr; n58). After sham operation or MI, rats were 31 randomized to receive creatine-free chow (fish protein 2.5. P NMR magnetization transfer measurements of replaced by soy bean; Altromin, Lage, FRG), to which 0% creatine kinase kinetics (untreated) or 3% (creatine treated) creatine (Sigma, Deisenhofen, FRG) was added (% refers to the total For magnetization transfer experiments each broadband weight of chow) for a period of 8 weeks. We had pulse was preceded by a low-power, narrowband pulse at previously shown that this dose of creatine achieves a the resonance frequency of [g-P]ATP for 0 or 3.6 s as maximum increase in serum creatine levels without reducpreviously described [15] . Recycle times for each scan ing body weight [15] . Food intake was similar (32.460.5 were kept constant at 5.0 s. A saturation transfer experig / day) for all four groups. After 8 weeks, hearts were ment was acquired in 12 min. Stability of the preparation isolated and perfused. Isolated hearts were given a 15-min was assessed by comparing one-pulse spectra obtained stabilization period, during which end-diastolic pressure before and after each magnetization transfer experiment.
was set to 10 mmHg by adjusting balloon volume. Magnetization transfer measurements of the forward CK Thereafter, pressure-volume curves were obtained as reaction, phosphocreatine→[g-P]ATP, were analyzed acdescribed above. Hearts were allowed to restabilize at cording to the two-site chemical exchange model of Forsen 31 EDP510 mmHg. One 5-min 'one-pulse' P NMR specand Hoffman [20] , providing estimates of the pseudo trum was then recorded. A saturation transfer measurement first-order rate constant (K ). Multiplying the rate confor of CK reaction velocity followed. Finally, another 5-min stant by substrate concentration yielded reaction velocity 31 'one-pulse' P NMR spectrum was recorded to test for [19] . metabolic stability during the saturation transfer measurement. At the completion of the protocol, hearts were saved 2.6. Measurement of creatine content as described for determination of infarct size and measurement of creatine content. In addition, at the time of At the end of the experiment, the right ventricular free sacrifice, blood was collected and centrifuged for dewall was cut off and was rapidly frozen in liquid nitrogen termination of serum creatine levels. for determination of total creatine content by high pressure liquid chromatography (HPLC) as previously described [15, 21] . Free creatine was then calculated for each heart as 2.9. Statistical analysis total creatine minus phosphocreatine. Non-collagen protein was measured by the method of Lowry et al. [22] . In
Results were compared using an unpaired, Bonferronianalogy to high-energy phosphate concentrations, free corrected t-test [25] . The following comparisons between creatine concentrations were expressed in mmol / l, assumgroups were made: Sh vs. [15] , and were expressed in mmol / l. statistical significance. Table 1 shows infarct sizes, heart weights, body weights terms, coronary flow was significantly reduced in the and their ratios for the four experimental groups. Infarct untreated MI group. Interestingly, however, this decrease size was similar for creatine-treated and untreated infarcted of coronary flow was prevented by chronic creatine animals (36 vs. 37%). Inspite of the loss of almost 40% of feeding of infarcted hearts. left ventricular tissue due to infarction, marginally increased heart weights and heart weight / body weight ratios 3.
Energy metabolism in sham and infarcted, treated in both MI groups attest to hypertrophy of residual intact
and untreated hearts myocardial tissue due to remodeling. Creatine feeding of 31 MI hearts did not change heart weights or heart weight / Fig. 2 shows typical P NMR spectra from the four body weight ratios.
experimental groups. The spectra demonstrate the reduction of the phosphocreatine resonance area that occurs 3.2. Mechanical performance and coronary flow post-MI. This was observed for both untreated and creatine-treated animals. Table 2 shows mean metabolite Fig. 1 shows pressure-volume curves for left ventricular concentrations for the experimental groups. ATP convolume and developed pressure from all experimental centrations were assumed to be as previously described groups. As it is typical for this model, infarcted groups (see Section 2); ATP levels remain constant in this heart showed a displacement of the pressure-volume curve failure model. Creatine feeding did not alter phosphoctowards higher volumes (dilatation) and lower developed reatine content in sham hearts, and phosphocreatine levels pressures (dysfunction). During chronic creatine feeding, were reduced to 81% in untreated MI and to 83% in pressure-volume curves did not change significantly for treated MI groups; similarly, free creatine levels were both sham and MI hearts. In addition, Table 1 shows that reduced to 65 and 74%, respectively. Thus, chronic heart rate (recorded at EDP510 mmHg) was similar for all creatine feeding did not significantly alter the contents of phosphorylated and non-phosphorylated creatine in sham and in MI hearts. Also, cytosolic phosphorylation potentials were not significantly different among groups. Inorganic phosphate (P ) was low in all experimental i groups, the statistically significant increase of P in i creatine-fed MI hearts was small in absolute terms (11.4 mmol / l). Intracellular pH was similar for all groups. Table 2 also shows results of saturation transfer measurements of CK kinetics. Compared to sham hearts, where creatine feeding had no effect, CK reaction velocity ('energy reserve via CK') decreased by 35% in untreated and by 53% in treated MI groups. Thus, creatine feeding did not increase CK reaction velocity in either sham and MI hearts. Therefore, our data demonstrate that chronic
The curves for both infarcted groups show a right-and downward creatine feeding had no effect on cardiac function and displacement, attesting to left ventricular dilatation and dysfunction. Creatine feeding was without effect in both sham and MI hearts. steady state as well as dynamic high-energy phosphate metabolism in both normal and failing hearts. Serum effects of chronic creatine feeding on cardiac function and creatine levels were not significantly different between energy metabolism in a well-established model of heart sham and MI hearts and were increased |2-fold in both failure, i.e. in the rat heart post-myocardial infarction. creatine-treated groups.
Using this model, we have previously defined left ventricular dilatation, systolic and diastolic dysfunction, as they occur 2 months after coronary artery ligation in the 4. Discussion isolated heart model [1, 10, 26] , as well as in vivo [27] . In residual intact myocardium, ATP levels remain unchanged 4.1. Definition of the model [1] , phosphocreatine and free creatine levels decrease by up to 40% [1, 16] and the creatine kinase reaction velocity In the present study, we examine possible beneficial is reduced by |50% [1] . All these changes could be reproduced for the MI group in the present study. We also supplementation [13] . Species differences may exist, howpreviously showed that pharmacologic interventions such ever, since in rat, skeletal muscle creatine content could as angiotensin-converting-enzyme inhibitors [28] or betanot be increased by creatine feeding [15] . In skeletal receptor blockers [10] were able to fully or partially muscle, a 17% increase of creatine levels has functional reverse the functional and energetic deterioration occurring relevance, and maximum work output increases signifiafter MI. Thus, we studied a heart failure model where cantly (see Ref. [14] for a review). Based on these functional and energetic derangements are well defined and observations, it was conceivable that the same approach where beneficial pharmacologic interventions can be demwould also be effective for cardiac muscle. Although it onstrated to afford protection.
was shown before that normal cardiac muscle does not Our approach to increase myocardial creatine and, thus, increase its creatine content with increased serum creatine as it was hoped, phosphocreatine levels, was to chronically levels [15] , it was possible that this intervention is increase the extracellular creatine supply to the heart by effective for conditions where creatine is chronically feeding high dosages of creatine with the diet for 2 depleted. Furthermore, the regulation of myocardial months. In the present work, 3% creatine feeding increased creatine uptake and degradation in heart failure is still serum creatine levels significantly |2-fold in both sham completely unknown. We know of no published clinical and MI groups. At the same time, body weights were study of the effects of creatine treatment in heart failure unaltered by creatine feeding. Thus, we tested the effect of patients, but there are some initial studies related to chronically doubling the extracellular creatine supply to beneficial effects of phosphocreatine treatment (e.g. the heart on the development of mechanical and energetic [30, 31] ), where acute and subacute improvement of carderangement following coronary ligation.
diac function was observed. However, the creatine transporter does not transport phosphocreatine, and no other 4.2. Effects of oral creatine supplementation on mechanism for direct uptake of the polar compound mechanical function and energy metabolism in heart phosphocreatine by cardiomyocytes has been demonstrafailure ted. Thus, if phosphocreatine does have a beneficial effect in heart failure, it is not related to improvement of cardiac Whether changes in high-energy phosphate metabolism energetics but, likely, rather due to some indirect (vascular, contribute to contractile dysfunction in heart failure is an electrophysiologic or other) effect. old and still unresolved question [9] . Although direct proof
The results presented here unequivocally demonstrate is missing, it is conceivable that reduction of energy that the strategy to chronically provide high dosages of reserve via creatine kinase and failure to maintain a high creatine to the failing heart is ineffective in preventing the cytosolic phosphorylation potential and free energy change decrease of creatine content and of energy reserve via of ATP hydrolysis (DG) [24] are mechanisms contributing creatine kinase. Inspite of chronically doubling extracelluto cardiac failure. In the present work, we attempted to lar creatine concentrations, myocardial phosphorylated and prevent the decrease of phosphocreatine and free creatine non-phosphorylated creatine levels as well as creatine in heart failure by increasing creatine supply to the heart. kinase reaction velocity all remained unaffected. In light of In case this intervention were successful, we could test these findings, it was not surprising that creatine feeding whether maintenance of high (phospho-) creatine content had no effect on functional consequences of left ventricular has beneficial functional effects.
remodeling post-MI with the exception of maintenance of In the mammalian organism, creatine is synthesized by coronary flow. Since heart creatine levels could not be liver and kidney and, in addition, is supplied with a increased with higher serum creatine levels, we could not non-vegetarian diet (see Ref. [29] for a review). Cartest the hypothesis that maintaining high cardiac creatine diomyocytes lack the enzymes required for creatine synlevels during the development of heart failure has benefithesis and, instead, accumulate creatine via a specific cial functional effects. Therefore, inspite of a lack of effect 1 membrane protein, the Na -creatine cotransporter, which of creatine feeding, our results do not argue against a has recently been cloned [12] , against a large concentration causal role of energy metabolism in heart failure, but also gradient [12, 29] . Intracellularly, creatine is phosphorylated do not provide new evidence in support of this concept. to phosphocreatine via creatine kinase. The degradation of We can only speculate on the reasons why higher phosphocreatine and creatine occurs non-enzymatically via extracellular creatine levels are ineffective in increasing spontaneous decarboxylation and passive transmembrane creatine levels and mechanical work in the normal or diffusion [12] , processes unlikely to be regulated. Therefailing heart. There are currently no data available on the fore, the obvious approach to attempt to increase intracelregulation of creatine transport under in vivo conditions, lular creatine content is to increase the substrate supply to and speculations have to rely on results obtained from cell the creatine transporter by raising extracellular creatine culture models, none of which have used cardiomyocytes levels. Previous work has shown that in human skeletal from failing hearts. Creatine transporter kinetics were muscle, this approach is successful: Here, total creatine shown to be dependent on Na / K-ATPase activity, beta -none of these mechanisms is likely to bear on our studies. again arguing against a pathophysiological role for the One possible explanation, however, is that both in human increase of inorganic phosphate in creatine-treated MI muscle cells as well as in G8 myoblasts, creatine transporhearts. ter activity was inversely related to extracellular creatine In summary, we have shown that chronically providing supply, i.e. was downregulated by high and upregulated by failing rat hearts with increased extracellular creatine fails low extracellular creatine concentrations [33] . Thus, the to elicit beneficial structural, functional and energetic most likely explanation for the failure of dietary creatine to effects. The additional creatine is not accumulated by the increase heart creatine stores is that the creatine transporter heart. Thus, creatine treatment does not seem to be a activity is downregulated under these circumstances, therepromising approach for the treatment of heart failure. by preventing an increase of intracellular creatine concentrations. In our study, creatine transporter levels were not directly determined, and it will be important to do this
